[Current therapeutic approach to diabetic macular edema refractory to laser coagulation].
The paper presents the evolution of a diabetic patient with CSME resistant to laser treatment. The intravitreal injection of Triamcinolone Acetonid represented a very efficient therapeutic solution the visual accuity improving for a period of 7-9 months.
Davidescu
Livia
L
Clinica de Oftalmologie Craiova.
Baltă
F
F
Mocanu
Carmen
C
Puşcaşu
Cristina Ramona
CR
Olaru
A
A
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D056965:Injections, Intraocular; D017075:Laser Coagulation; D008269:Macular Edema / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects*
D000893:Anti-Inflammatory Agents; D014222:Triamcinolone Acetonide